Cansortium (XCNQ:TIUM.U) Days Payable : 42.94 (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cansortium Days Payable?

Cansortium's average Accounts Payable for the three months ended in Sep. 2024 was $6.9 Mil. Cansortium's Cost of Goods Sold for the three months ended in Sep. 2024 was $14.6 Mil. Hence, Cansortium's Days Payable for the three months ended in Sep. 2024 was 42.94.

The historical rank and industry rank for Cansortium's Days Payable or its related term are showing as below:

XCNQ:TIUM.U' s Days Payable Range Over the Past 10 Years
Min: 45.69 Med: 92.36 Max: 345.11
Current: 48.14

During the past 6 years, Cansortium's highest Days Payable was 345.11. The lowest was 45.69. And the median was 92.36.

XCNQ:TIUM.U's Days Payable is ranked worse than
75.32% of 952 companies
in the Drug Manufacturers industry
Industry Median: 85.205 vs XCNQ:TIUM.U: 48.14

Cansortium's Days Payable declined from Sep. 2023 (44.55) to Sep. 2024 (42.94). It may suggest that Cansortium accelerated paying its suppliers.

Cansortium Days Payable Historical Data

The historical data trend for Cansortium's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cansortium Days Payable Chart

Cansortium Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

222.91

102.69

82.02

55.58

45.69

Cansortium Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															44.55	34.41	51.78	77.00	42.94

Competitive Comparison of Cansortium's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Cansortium's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cansortium's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cansortium's Days Payable distribution charts can be found below:

* The bar in red indicates where Cansortium's Days Payable falls into.

Cansortium Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cansortium's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (6.931	+	5.525)	/	2 )	/	49.757	*	365
=	6.228					/	49.757	*	365
=	45.69

Cansortium's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (5.676	+	8.035)	/	2 )	/	14.569	*	365 / 4
=	6.8555					/	14.569	*	365 / 4
=	42.94

Cansortium Days Payable Related Terms

Thank you for viewing the detailed overview of Cansortium's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cansortium Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (XCNQ:TIUM.U) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CNTMF:USA 2WM:Germany

Address

82 North East 26th Street, Unit 110, Miami, FL, USA, 33137

Website

https://getfluent.com

Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

Cansortium Headlines

No Headlines